[1]
|
Huelga, S.C., Vu, A.Q., Arnold, J.D., Liang, T.Y., Liu, P.P., Yan, B.Y., et al. (2012) Integrative genome-wide analysis reveals cooperative regulation of alternative splicing by hn RNP proteins. Cell Reports, 1, 167-178.
doi:10.1016/j.celrep.2012.02.001
|
[2]
|
Hirschi, B. and Kolligs, F.T. (2013) Alternative splicing of BRAF transcripts and characterization of C-terminally truncated B-Raf isoforms in colorectal cancer. International Journal of Cancer, 133, 590-596.
doi:10.1002/ijc.28061
|
[3]
|
Raso-Barnett, L., Banky, B., Barbai, T., Becsagh, P., Timar, J. and Raso, E. (2013) Demonstration of a melanoma-specific CD44 alternative splicing pattern that remains qualitatively stable, but shows quantitative changes during tumor progression. PLoS One, 8, e53883.
doi:10.1371/journal.pone.0053883
|
[4]
|
Warzecha, C.C. and Carstens, R.P. (2012) Complex changes in alternative pre-m RNA splicing may play a central role in the epithelial-to-mesenchymal transition (EMT). Seminars in Cancer Biology, 22, 417-427.
doi:10.1016/j.semcancer.2012.04.003
|
[5]
|
Finley, S.D. and Popel, A.S. (2012) Predicting the effects of anti-angiogenic agents targeting specific VEGF isoforms. AAPS Journal, 14, 500-509.
|
[6]
|
Tang, X., Li, J., Yu, B., Su, L., Yu, Y., Yan, M., et al. (2013) Osteopontin splice variants differentially exert clinicopathological features and biological functions in gastric cancer. International Journal of Biological Sciences, 9, 55-66. doi:10.7150/ijbs.5280
|
[7]
|
Ben-Hur, V., Denichenko, P., Siegfried, Z., Maimon, A., Krainer, A., Davidson, B., et al. (2013) S6K1 alternative splicing modulates its oncogenic activity and regulates mTORC1. Cell Reports, 3, 103-115.
doi:10.1016/j.celrep.2012.11.020
|
[8]
|
Yang, W. and Yee, A.J. (2013) Versican V2 isoform enhances angiogenesis by regulating endothelial cell activities and fibronectin expression. FEBS Letters, 587, 185-192. doi:10.1016/j.febslet.2012.11.023
|
[9]
|
Tabu, K., Bizen, N., Taga, T. and Tanaka, S. (2013) Gene regulation of prominin-1 (CD133) in normal and cancerous tissues. Advances in Experimental Medicine and Biology, 777, 73-85. doi:10.1007/978-1-4614-5894-4_5
|
[10]
|
Das, S., Anczukow, O., Akerman, M. and Krainer, A.R. (2012) Oncogenic splicing factor SRSF1 is a critical transcriptional target of MYC. Cell Reports, 1, 110-117.
doi:10.1016/j.celrep.2011.12.001
|
[11]
|
Kim, I., Kwak, H., Lee, H.K., Hyun, S. and Jeong, S. (2012) Beta-catenin recognizes a specific RNA motif in the cyclooxygenase-2 m RNA 3’-UTR and interacts with HUR in colon cancer cells. Nucleic Acids Research, 40, 6863-6872. doi:10.1093/nar/gks331
|
[12]
|
Alagaratnam, S., Harrison, N., Bakken, A.C., Hoff, A.M., Jones, M., Sveen, A., et al. (2013) Transforming pluripotency: An exon-level study of malignancy-specific transcripts in human embryonal carcinoma and embryonic stem cells. Stem Cells and Development, 22, 1136-1146.
doi:10.1089/scd.2012.0369
|
[13]
|
Saitoh, M. and Miyazawa, K. (2012) Transcriptional and post-transcriptional regulation in TGF-Beta-mediated epithelial-mesenchymal transition. The Journal of Biochemistry, 151, 563-571. doi:10.1093/jb/mvs040
|
[14]
|
Cohen-Eliav, M., Golan-Gerstl, R., Siegfried, Z., Andersen, C.L., Torsen, K., Orntoft, T.F., et al. (2012) The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancers. The Journal of Pathology, 229, 630-639.
|
[15]
|
Schultz, J.C., Vu, N., Shultz, M.D., Mba, M.U., Shapiro, B.A. and Chalfant, C.E. (2012) The proto-oncogene PKC1 regulates the alternative splicing of Bcl-x Pre-m RNA. Molecular Cancer Research, 10, 660-669.
doi:10.1158/1541-7786.MCR-11-0363
|
[16]
|
Wan, J. (2012) Antisense-mediated exon skipping to shift alternative splicing to treat cancer. Methods in Molecular Biology, 867, 201-208.
doi:10.1007/978-1-61779-767-5_13
|
[17]
|
Spitali, P. and Aartsma-Rus, A. (2012) Splice modulating therapies for human disease. Cell, 148, 1085-1088.
doi:10.1016/j.cell.2012.02.014
|
[18]
|
Di Modugno, R., Iapicca, P., Boudreau, A., Mottolese, M., Terrenato, I., Perracchio, L., et al. (2012) Splicing program of human MENA produces a previously undescribed isoform associated with invasive, mesenchymal-like breast tumors. Proceedings of the National Academy of Sciences of the United States of America, 109, 19280-19285. doi:10.1073/pnas.1214394109
|
[19]
|
Li, G., Bahn, J.H., Lee, J.H., Peng, G., Chen, Z., Nelson, S.F., et al. (2012) Identification of allele-specific alternative m RNA processing via transcriptome sequencing. Nucleic Acids Research, 40, e104.
doi:10.1093/nar/gks280
|
[20]
|
Carpenter, R.L. and Lo, H.W. (2012) Identification, functional characterization and pathobiological significance of GLI1 isoforms in human cancers. Vitamins & Hormones, 88, 115-140.
|
[21]
|
Bonnal, S., Vigevani, L. and Valcarcel, J. (2012) The spliceosome as a target of novel antitumour drugs. Nature Reviews Drug Discovery, 11, 847-859.
doi:10.1038/nrd3823
|
[22]
|
Miura, K., Fujibuchi, W. and Unno, M. (2012) Splice isoforms as therapeutic targets for colorectal cancer. Carcinogenesis, 33, 2311-2319. doi:10.1093/carcin/bgs347
|
[23]
|
Niland, C.N., Merry, C.R. and Khalil, A.M. (2012) Emerging roles for long non-coding RNAs in cancer and neurological disorders. Frontiers in Genetics, 3, 25.
doi:10.3389/fgene.2012.00025
|
[24]
|
Carpenter, R.L. and Lo, H.W. (2012) Hedgehog pathway and GLI1 isoforms in human cancer. Discovery Medicine, 13, 105-113.
|
[25]
|
Dardenne, E., Pierredon, S., Driouch, K., Gratadou, L., Lacroix-Triki, M., Espinoza, M.P., et al. (2012) Splicing switch of an epigenetic regulator by RNA helicases promotes tumor-cell invasiveness. Nature Structural & Molecular Biology, 19, 1139-1146. doi:10.1038/nsmb.2390
|
[26]
|
Wu, C.F., Tan, G.H., Ma, C.C. and Li, L. (2013) The non-coding RNA llme23 drives the malignant property of human melanoma cells. Journal of Genetics and Genomics, 40, 179-188. doi:10.1016/j.jgg.2013.03.001
|
[27]
|
Eswaran, J., Horvath, A., Godbole, S., Reddy, S.D., Mudvari, P., Ohshiro, K., et al. (2013) RNA sequencing of cancer reveals novel splicing alterations. Scientific Reports, 3, Article ID: 1689. doi:10.1038/srep01689
|